NWBO has had years to attract BP and NONE have been interested. UK approval, if it ever happens, has little attractiveness after being FDA told them not to bother filing. Merck, who has seen ALL of DCVax-Ls data up close, has passed buying at least four other oncology biotechs. In addition, there hasn't been a BP deal with an OTC biotech drug company in the last decade. Not going to happen.
Market Data 
Markets 
AI
